Financials

  • Market Capitalization 47.7 M
  • Employee 115
  • Founded 1998
  • CEO N/A
  • Website www.celularity.com
  • Headquarter Delaware, United States
  • FIGI BBG00P2RTT34
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.31
Rapporto prezzo/fatturato
1.07

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4181
SER
Serina Therapeutics, Inc. Common Stock
1.90 USD-5.00%-6.40%-16.67%+14.11%48.26 M USD
4182
IMA
ImageneBio, Inc. - Common Stock
4.25 USD+0.24%-9.57%-18.58%-45.30%48.24 M USD
4190
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.98 USD0.00%+4.26%+1.03%-39.13%47.63 M USD
4202
APLM
Apollomics Inc. - Class A Ordinary Shares
21.17 USD-1.53%-9.91%-8.67%+15.05%46.49 M USD

Notizie